Differential effects of corticosteroids and pimecrolimus on the developing skin immune system in humans and mice (Q43474336)

23 November 2017

title

Differential effects of corticosteroids and pimecrolimus on the developing skin immune system in humans and mice (English)

1 reference

23 November 2017

8

Georg Stingl

1 reference

23 November 2017

Simone Meindl

1

1 reference

23 November 2017

Christine Vaculik

2

1 reference

23 November 2017

Josef G Meingassner

3

1 reference

23 November 2017

Gero Kramer

4

1 reference

23 November 2017

Johnnie Akgün

5

1 reference

23 November 2017

Marion Prior

6

1 reference

23 November 2017

Anton Stuetz

7

1 reference

23 November 2017

Adelheid Elbe-Bürger

9

1 reference

23 November 2017

language of work or name

English

0 references

publication date

19 March 2009

1 reference

Journal of Investigative Dermatology

23 November 2017

published in

1 reference

23 November 2017

volume

129

1 reference

23 November 2017

issue

9

1 reference

23 November 2017

page(s)

2184-2192

1 reference

Neonatal adaptive immunity comes of age

23 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.50

7 January 2021

https://api.crossref.org/works/10.1038%2FJID.2009.50

1 reference

7 January 2021

Autocrine IL-10 partially prevents differentiation of neonatal dendritic epidermal leukocytes into Langerhans cells

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.50

7 January 2021

Fetal and neonatal murine skin harbors Langerhans cell precursors.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.50

7 January 2021

Blood plasmacytoid dendritic cell responses to CpG oligodeoxynucleotides are impaired in human newborns

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.50

7 January 2021

Acquisition of immune function during the development of the Langerhans cell network in neonatal mice

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.50

7 January 2021

Overexpression of IL-4 alters the homeostasis in the skin

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.50

7 January 2021

The epidemiology and experience of atopic eczema during childhood: a discussion paper on the implications of current knowledge for health care, public health policy and research

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.50

7 January 2021

Deficient IL-12(p35) gene expression by dendritic cells derived from neonatal monocytes.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.50

7 January 2021

A defect in nucleosome remodeling prevents IL-12(p35) gene transcription in neonatal dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.50

7 January 2021

Adverse effects of topical glucocorticosteroids

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.50

7 January 2021

Corticosteroids but not pimecrolimus affect viability, maturation and immune function of murine epidermal Langerhans cells

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.50

7 January 2021

Pimecrolimus leads to an apoptosis-induced depletion of T cells but not Langerhans cells in patients with atopic dermatitis

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.50

7 January 2021

Both pimecrolimus and corticosteroids deplete plasmacytoid dendritic cells in patients with atopic dermatitis

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.50

7 January 2021

Pimecrolimus does not affect the differentiation, maturation and function of human monocyte-derived dendritic cells, in contrast to corticosteroids

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.50

7 January 2021

Differential inhibition of primary versus preactivated T cells by pimecrolimus but not by tacrolimus in vitro

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.50

7 January 2021

Characterization of the glucocorticoid receptor in human skin

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.50

7 January 2021

https://api.crossref.org/works/10.1038%2FJID.2009.50

1 reference

7 January 2021

SDZ ASM 981: an emerging safe and effective treatment for atopic dermatitis

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.50

7 January 2021

Dexamethasone inhibits maturation and alters function of monocyte-derived dendritic cells from cord blood

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.50

7 January 2021

Pimecrolimus does not affect Langerhans cells in murine epidermis

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.50

7 January 2021

Perceptions of physicians and pediatric patients about atopic dermatitis, its impact, and its treatment

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.50

7 January 2021

CD1a and CD1c cell sorting yields a homogeneous population of immature human Langerhans cells.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.50

7 January 2021

Neonatal dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.50

7 January 2021

Novel mechanism of steroid action in skin through glucocorticoid receptor monomers.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.50

7 January 2021

Clearing of psoriasis by a novel immunosuppressive macrolide

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.50

7 January 2021

A short-term trial of tacrolimus ointment for atopic dermatitis. European Tacrolimus Multicenter Atopic Dermatitis Study Group

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.50

7 January 2021

Differential Effects of Cytokines and Immunosuppressive Drugs on CD40, B7–1, and B7–2 Expression on Purified Epidermal Langerhans Cells

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.50

7 January 2021

Tacrolimus ointment causes inflammatory dendritic epidermal cell depletion but no Langerhans cell apoptosis in patients with atopic dermatitis

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.50

7 January 2021

Atopic dermatitis and the atopic march

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.50

7 January 2021

Novel genomic effects of glucocorticoids in epidermal keratinocytes: inhibition of apoptosis, interferon-gamma pathway, and wound healing along with promotion of terminal differentiation.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.50

7 January 2021

Discovery of topical calcineurin inhibitors and pharmacological profile of pimecrolimus

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.50

7 January 2021

Ontogeny of Langerin/CD207 expression in the epidermis of mice.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.50

7 January 2021

How epidemiology has challenged 3 prevailing concepts about atopic dermatitis

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.50

7 January 2021

Inhibition of T-cell activation in vitro in human peripheral blood mononuclear cells by pimecrolimus and glucocorticosteroids and combinations thereof.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.50

7 January 2021

Pimecrolimus for the treatment of inflammatory skin disease

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.50

7 January 2021

Corticosteroids prevent generation of CD34+-derived dermal dendritic cells but do not inhibit Langerhans cell development

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.50

7 January 2021

Identifiers

DOI

10.1038/JID.2009.50

1 reference

23 November 2017

1 reference